Ballicules.com

Sildenafil

VIAGRA

What it isPDE5 inhibitor; erectile dysfunction and pulmonary arterial hypertension.

Why this onePDE6 spillover produces its characteristic blue-tinted vision, distinguishing it from other PDE5 inhibitors.

What limits itNitrates can cause fatal hypotension and are absolutely contraindicated; CYP3A4 inhibitors raise exposure.

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
Erectile dysfunctionAdult males50 mg PRN ~1 h before sexual activity25-100 mg PRN100 mg; once daily max frequency

Renal Mild-moderate (CLcr 30-80): no adjustment; severe (<30 mL/min): consider start 25 mg

Hepatic Consider start 25 mg (Child-Pugh A/B); Child-Pugh C not studied

Maximum dosing frequency once per day

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Not indicated in females; no human data; animal studies show no adverse developmental outcomes

Lactation Not indicated in females; sildenafil and metabolite present in human milk (limited data)

NO BOXED WARNINGS

Principal riskFatal hypotension with nitrates

Cost, est. cash$10–$500/month

Generic entry2012

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Sildenafil ballicule

Sildenafil ballicule: receptor binding, kinetics and half-life diagram

Open Sildenafil in the interactive console ↗

Memory aids: mascots and interaction avatars

Sildenafil VIAGRA mascot mnemonic cartoon
“Slide to fill (Niagara)”
Sildenafil CYP3A4 substrate avatar
CYP3A4 substrate

Open Sildenafil in the interactive console ↗